Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 330


The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Trant CG, Lacerda TL, Carvalho NB, Azevedo V, Rosinha GM, Salcedo SP, Gorvel JP, Oliveira SC.

Infect Immun. 2010 May;78(5):2283-91. doi: 10.1128/IAI.01433-09. Epub 2010 Mar 1.


Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

de Souza Filho JA, de Paulo Martins V, Campos PC, Alves-Silva J, Santos NV, de Oliveira FS, Menezes GB, Azevedo V, Cravero SL, Oliveira SC.

Infect Immun. 2015 Apr;83(4):1458-64. doi: 10.1128/IAI.02790-14. Epub 2015 Feb 2.


Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice.

Rosinha GM, Freitas DA, Miyoshi A, Azevedo V, Campos E, Cravero SL, Rossetti O, Splitter G, Oliveira SC.

Infect Immun. 2002 Sep;70(9):5036-44.


DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.

Yang X, Thornburg T, Walters N, Pascual DW.

Vaccine. 2010 Jan 22;28(4):1069-74. doi: 10.1016/j.vaccine.2009.10.113. Epub 2009 Nov 13.


The role of the vacB gene in the pathogenesis of Brucella abortus.

Miyoshi A, Rosinha GM, Camargo IL, Trant CM, Cardoso FC, Azevedo V, Oliveira SC.

Microbes Infect. 2007 Mar;9(3):375-81. Epub 2007 Jan 4.


Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.

Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.

Vaccine. 2006 Apr 5;24(15):2910-6. Epub 2006 Jan 6.


Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.

Lacerda TL, Cardoso PG, Augusto de Almeida L, Camargo IL, Afonso DA, Trant CC, Macedo GC, Campos E, Cravero SL, Salcedo SP, Gorvel JP, Oliveira SC.

Vaccine. 2010 Aug 2;28(34):5627-34. doi: 10.1016/j.vaccine.2010.06.023. Epub 2010 Jun 19.


Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.

Zhu J, Larson CB, Ramaker MA, Quandt K, Wendte JM, Ku KP, Chen F, Jourdian GW, Vemulapalli R, Schurig GG, He Y.

Front Cell Infect Microbiol. 2011 Nov 25;1:10. doi: 10.3389/fcimb.2011.00010. eCollection 2011.


Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.

Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.

Vaccine. 2011 Apr 12;29(17):3106-10. doi: 10.1016/j.vaccine.2011.02.054. Epub 2011 Mar 3.


Characterization of betaine aldehyde dehydrogenase (BetB) as an essential virulence factor of Brucella abortus.

Lee JJ, Kim JH, Kim DG, Kim DH, Simborio HL, Min WG, Rhee MH, Lim JH, Chang HH, Kim S.

Vet Microbiol. 2014 Jan 10;168(1):131-40. doi: 10.1016/j.vetmic.2013.10.007. Epub 2013 Oct 22.


In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.

Wang Z, Niu J, Wang S, Lv Y, Wu Q.

Clin Vaccine Immunol. 2013 Feb;20(2):174-80. doi: 10.1128/CVI.00573-12. Epub 2012 Dec 12.


Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.

Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.

Vet Microbiol. 2004 Sep 8;102(3-4):237-45.


The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.

Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L.

Vet Microbiol. 2011 Aug 5;151(3-4):354-62. doi: 10.1016/j.vetmic.2011.03.031. Epub 2011 Apr 4.


Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].


Brucella abortus bacA mutant induces greater pro-inflammatory cytokines than the wild-type parent strain.

Parent MA, Goenka R, Murphy E, Levier K, Carreiro N, Golding B, Ferguson G, Roop RM 2nd, Walker GC, Baldwin CL.

Microbes Infect. 2007 Jan;9(1):55-62. Epub 2006 Dec 11.


Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.

Infect Immun. 2007 Oct;75(10):4923-32. Epub 2007 Jul 30.


Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Witonsky SG.

FEMS Immunol Med Microbiol. 2010 Nov;60(2):147-55. doi: 10.1111/j.1574-695X.2010.00729.x. Epub 2010 Aug 31.


Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA.

Clin Vaccine Immunol. 2012 Feb;19(2):249-60. doi: 10.1128/CVI.05321-11. Epub 2011 Dec 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk